Imperial College London
Alternate

Professor Michael Loebinger

Faculty of Medicine, National Heart & Lung Institute

Professor of Practice (Respiratory Medicine)
 
 
 
//

Contact

 

+44 (0)20 7351 8337m.loebinger

 
 
//

Location

 

Fulham RoadRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Chalmers:2020:10.1056/NEJMoa2021713,
author = {Chalmers, JD and Haworth, CS and Metersky, ML and Loebinger, MR and Blasi, F and Sibila, O and O'Donnell, AE and Sullivan, EJ and Mange, KC and Fernandez, C and Zou, J and Daley, CL},
doi = {10.1056/NEJMoa2021713},
journal = {NEW ENGLAND JOURNAL OF MEDICINE},
pages = {2127--2137},
title = {Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis},
url = {http://dx.doi.org/10.1056/NEJMoa2021713},
volume = {383},
year = {2020}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Chalmers,JD
AU  - Haworth,CS
AU  - Metersky,ML
AU  - Loebinger,MR
AU  - Blasi,F
AU  - Sibila,O
AU  - O'Donnell,AE
AU  - Sullivan,EJ
AU  - Mange,KC
AU  - Fernandez,C
AU  - Zou,J
AU  - Daley,CL
DO  - 10.1056/NEJMoa2021713
EP  - 2137
PY  - 2020///
SN  - 0028-4793
SP  - 2127
TI  - Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
T2  - NEW ENGLAND JOURNAL OF MEDICINE
UR  - http://dx.doi.org/10.1056/NEJMoa2021713
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000595759900010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 383
ER  -
Download